Health · NASDAQ · USD · Data as of 2026-07-30
AUM
$190.03M
Expense ratio
0.75%
Yield
0.05%
YTD return
+18.50%
Last price
$40.65
Thematic Sector · Coverage 100% · medium
Today
49.8
Outlook
49.1
Block A (composite-derived)
47.9
Block C (market behavior)
50.2
Today overlay (Block D)
0.0
Outlook overlay (Block D)
0.0
today_score = clip(0,100, 50 + 0.15·(A−50) + 0.60·(C−50) + D_today). Block B (holdings rollup) is in Phase 3 development; β=0 caps the natural range at ~12.5–87.5 in Preview v0.9. Formula version tide-etf-v1.0.0.
47.9
Coverage 100% · high
Liquidity
60.7
Expenses
45.0
Performance
48.2
Volatility
28.6
Dividend
10.4
Concentration
40.0
Smart Money
61.1
Activist
93.9
Formula version composite-v1.0.0. Axes hover to see why a sub-score is missing.
Tema Oncology ETF (CANC) is an exchange-traded fund from Tema Global Limited in the Mixed asset class. Launched in 2023. Assets under management: 175,747,104.
Bullish Whales composite rating: 48 out of 100. Evidence coverage 100% across 8 of 8 axes. Strongest axes: activist exposure, smart-money flow, liquidity.
Annualized one-year realized volatility 23%, classified high. Weakest axes: dividend, volatility.
Top-10 weight 0%, diversified, led by RVMD. Trailing yield 0%.
etf_composite_score_current · activist_score, composite_score, confidence, coverage_pct, dividend_score, liquidity_score, smart_money_score, volatility_scoreetf_fundamentals_td · dividend_frequency, yieldetf_holdings_top10 · holding_symbol, weightetf_universe · asset_class, aum_usd, fund_type, inception_date, issuer, name, ticker, volatility_1yTema Oncology ETF is an exchange-traded fund focused on the oncology sector, offering investors exposure to companies engaged in the research, development, and commercialization of therapies for cancer treatment. Its primary function is to track and replicate the performance of a specified index of global companies operating within the healthcare industry, particularly those specializing in oncology. Notable features of this fund include its diversified portfolio, which potentially includes biotech firms, pharmaceutical companies, and healthcare organizations involved in innovative cancer treatment methodologies. It plays a role in the financial market by providing investors with an opportunity to invest in a specific subset of the healthcare sector, enabling diversification and potential risk reduction compared to investing in individual stocks. By facilitating targeted exposure to advancements in cancer research and treatment, the Tema Oncology ETF contributes to the broader investment landscape within the healthcare field.
30-day change
$13.89M
90-day change
—
Current AUM: $190,030,368. AUM change is computed from rolling daily fundamentals snapshots; it reflects total net-asset deltas (creations/redemptions + market value moves), not pure share creations.
Fund documents (fact sheets, prospectuses, semi-annual reports) for CANC are coming soon. The BW fund-document archive will surface PDFs alongside a metadata index for searchability.